Expect Consolidation in Pharma, But Not From Merck: CEO

Merck Chairman of the Executive Board and CEO Karl-Ludwig Kley discusses his company’s acquisition of Sigma-Aldrich, consolidation in the Pharmaceuticals and the outlook for the sector. He speaks to Bloomberg’s Anna Edwards on “Countdown.” (Source: Bloomberg)

JPMorgan's David Kelly Questions Phillips Curve Model
53:41 - David Kelly, JPMorgan Asset Management's chief global strategist, discusses the economic impact of stagnate inflation with Bloomberg's Vonnie Quinn on "Bloomberg Markets." (Source: Bloomberg)
  • Icahn, Ackman Fight for Future of Herbalife
  • Janus Henderson’s Crooke on Soaring Global Dividends
  • ADP Rejects Ackman’s Board Nominees